Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
Dyne Therapeutics (Nasdaq: DYN), a clinical-stage muscle disease company, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event is scheduled for September 5, 2024, at 4:05 p.m. ET in New York.
Management will engage in a fireside chat during the conference. Investors and interested parties can access a live webcast of the presentation through Dyne's website in the Investors & Media section. The replay will remain available for 90 days after the event.
This participation highlights Dyne's commitment to advancing innovative therapeutics for individuals with genetically driven muscle diseases and provides an opportunity for the company to share insights with the healthcare investment community.
Dyne Therapeutics (Nasdaq: DYN), un'azienda in fase clinica che si occupa di malattie muscolari, ha annunciato la sua partecipazione alla 22ª Conferenza Annuale Globale sulla Sanità di Morgan Stanley. L'evento è programmato per 5 settembre 2024, alle 16:05 ET a New York.
La direzione parteciperà a una chiacchierata informale durante la conferenza. Gli investitori e le parti interessate possono accedere a un webcast dal vivo della presentazione attraverso il sito web di Dyne nella sezione Investitori & Media. La replica sarà disponibile per 90 giorni dopo l'evento.
Questa partecipazione sottolinea l'impegno di Dyne nell'avanzare terapie innovative per individui con malattie muscolari di origine genetica e offre all'azienda l'opportunità di condividere informazioni con la comunità degli investimenti nel settore sanitario.
Dyne Therapeutics (Nasdaq: DYN), una empresa en etapa clínica dedicada a enfermedades musculares, ha anunciado su participación en la 22ª Conferencia Anual Global de Salud de Morgan Stanley. El evento está programado para el 5 de septiembre de 2024, a las 4:05 p.m. ET en Nueva York.
La dirección participará en una charla informal durante la conferencia. Los inversores y partes interesadas pueden acceder a un webcast en vivo de la presentación a través del sitio web de Dyne en la sección de Inversores y Medios. La repetición estará disponible durante 90 días después del evento.
Esta participación destaca el compromiso de Dyne con el avance de terapias innovadoras para personas con enfermedades musculares de origen genético y brinda a la empresa la oportunidad de compartir información con la comunidad de inversión en salud.
Dyne Therapeutics (Nasdaq: DYN), 임상 단계의 근육 질환 전문 회사가 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 이 행사는 2024년 9월 5일 오후 4시 5분 ET에 뉴욕에서 열릴 예정입니다.
경영진은 컨퍼런스 동안 자유로운 대화에 참여할 것입니다. 투자자와 관심 있는 이들은 Dyne의 웹사이트 투자자 및 미디어 섹션을 통해 발표의 실시간 웹캐스트에 접속할 수 있습니다. 재생은 행사가 끝난 후 90일 동안 이용 가능합니다.
이번 참가로 Dyne은 유전적으로 유발된 근육 질환을 가진 개인들을 위한 혁신적인 치료법을 발전시키기 위한 의지를 강조하며, 의료 투자 커뮤니티와 통찰을 공유할 수 있는 기회를 제공합니다.
Dyne Therapeutics (Nasdaq: DYN), une entreprise en phase clinique spécialisée dans les maladies musculaires, a annoncé sa participation à la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. L'événement est prévu pour le 5 septembre 2024, à 16h05 ET à New York.
La direction participera à une discussion informelle durant la conférence. Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via le site web de Dyne, dans la section Investisseurs et Médias. Le rediffusion sera disponible pendant 90 jours après l'événement.
Cette participation souligne l'engagement de Dyne à faire progresser des thérapies innovantes pour les individus atteints de maladies musculaires d'origine génétique et fournit à l'entreprise une occasion de partager des informations avec la communauté d'investissement en santé.
Dyne Therapeutics (Nasdaq: DYN), ein Unternehmen in der klinischen Phase für Muskelerkrankungen, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley angekündigt. Die Veranstaltung findet am 5. September 2024, um 16:05 Uhr ET in New York statt.
Das Management wird während der Konferenz an einem informellen Gespräch teilnehmen. Investoren und interessierte Parteien können über die Investor- und Mediensektion der Dyne-Website auf ein Live-Webcast der Präsentation zugreifen. Die Wiederholung wird für 90 Tage nach der Veranstaltung verfügbar sein.
Diese Teilnahme unterstreicht Dyndes Engagement für die Entwicklung innovativer Therapeutika für Menschen mit genetisch bedingten Muskelerkrankungen und bietet dem Unternehmen die Möglichkeit, Einblicke mit der Investitionsgemeinschaft im Gesundheitswesen zu teilen.
- None.
- None.
WALTHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference being held in New York on Thursday, September 5, 2024 at 4:05 p.m. ET.
A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days following the presentation.
About Dyne Therapeutics
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Contact:
Amy Reilly
areilly@dyne-tx.com
857-341-1203
FAQ
When is Dyne Therapeutics (DYN) presenting at the Morgan Stanley Healthcare Conference?
How can I watch Dyne Therapeutics' (DYN) presentation at the Morgan Stanley conference?
How long will the replay of Dyne Therapeutics' (DYN) Morgan Stanley conference presentation be available?
What is the focus of Dyne Therapeutics (DYN) as a company?
